(19)
(11) EP 1 435 990 A1

(12)

(43) Date of publication:
14.07.2004 Bulletin 2004/29

(21) Application number: 02801430.6

(22) Date of filing: 18.10.2002
(51) International Patent Classification (IPC)7A61K 38/12, A61K 9/00, A61P 35/00
(86) International application number:
PCT/GB2002/004735
(87) International publication number:
WO 2003/033012 (24.04.2003 Gazette 2003/17)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 19.10.2001 US 348449 P
31.10.2001 WO PCT/GB01/04821
26.09.2002 GB 0222409

(71) Applicant: PHARMA MAR, S.A.
28760 Tres Cantos,Madrid (ES)

(72) Inventors:
  • JIMENO, José,Pharma Mar, S.A.
    Tres Cantos,E-28760 Madrid (ES)
  • LOPEZ LAZARO, Luis,Pharma Mar, S.A.
    Tres Cantos,E-28760 Madrid (ES)
  • RUIZ CASADO, Ana,Pharma Mar, S.A.
    Tres Cantos,E-28760 Madrid (ES)
  • IZQUIERDO, Miguel, Angel,Pharma Mar, S.A.
    Tres Cantos,E-28760 Madrid (ES)
  • PAZ-ARES, Luis
    E-28041 Madrid (ES)
  • TRIGO, Jose, Manuel
    E-08035 Barcelona (ES)
  • SCHELLENS, Jan
    NL-1066 CX Amsterdam (NL)

(74) Representative: Ruffles, Graham Keith 
Marks & Clerk66-68 Hills Road
Cambridge,Cambridgeshire, CB2 1LA
Cambridge,Cambridgeshire, CB2 1LA (GB)

   


(54) KAHALALIDE COMPOUNDS FOR USE IN CANCER THERAPY